Davide Capodanno

95.5k total citations · 10 hit papers
489 papers, 14.0k citations indexed

About

Davide Capodanno is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Davide Capodanno has authored 489 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 395 papers in Cardiology and Cardiovascular Medicine, 264 papers in Surgery and 99 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Davide Capodanno's work include Coronary Interventions and Diagnostics (218 papers), Antiplatelet Therapy and Cardiovascular Diseases (189 papers) and Acute Myocardial Infarction Research (127 papers). Davide Capodanno is often cited by papers focused on Coronary Interventions and Diagnostics (218 papers), Antiplatelet Therapy and Cardiovascular Diseases (189 papers) and Acute Myocardial Infarction Research (127 papers). Davide Capodanno collaborates with scholars based in Italy, United States and United Kingdom. Davide Capodanno's co-authors include Dominick J. Angiolillo, Corrado Tamburino, Piera Capranzano, Gian Paolo Ussia, Marco Barbanti, Roxana Mehran, Giuseppe Gargiulo, Marco Valgimigli, Anna Sonia Petronio and Antonio Colombo and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Davide Capodanno

459 papers receiving 13.8k citations

Hit Papers

Incidence and Predictors of Early and Late Mortality Afte... 2011 2026 2016 2021 2011 2013 2017 2015 2018 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis
    2011 835 citations Davide Capodanno et al. profile →
  2. Incidence, Predictors, and Outcomes of Aortic Regurgitation After Transcatheter Aortic Valve Replacement
    2013 522 citations Giuseppe Tarantini, Davide Capodanno et al. Journal of the American College of Cardiology profile →
  3. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
    2017 337 citations Davide Capodanno, Robert A. Byrne et al. European Heart Journal profile →
  4. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
    2015 307 citations Davide Capodanno et al. profile →
  5. ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy
    2018 221 citations Davide Capodanno, Marco Valgimigli et al. Journal of the American College of Cardiology profile →
  6. 2021 ESC/EACTS Guidelines for the management of valvular heart disease
    2022 171 citations Milan Milojevic, Davide Capodanno et al. profile →
  7. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
    2021 132 citations Mattía Galli, Stefano Benenati et al. profile →
  8. Pharmacology and Clinical Development of Factor XI Inhibitors
    2023 76 citations Antonio Greco, Claudio Laudani et al. profile →
  9. Coronary Angiography, Intravascular Ultrasound, and Optical Coherence Tomography for Guiding of Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis
    2024 43 citations Daniele Giacoppo, Claudio Laudani et al. profile →
  10. Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects
    2025 16 citations Antonio Greco, Simone Finocchiaro et al. profile →

Peers

Davide Capodanno
Marco Roffi Switzerland
Franz‐Josef Neumann Germany
Pascal Vranckx Belgium
Howard C. Herrmann United States
Eugenia Nikolsky United States
Allan L. Klein United States
C. Michael Gibson United States
Mitchell W. Krucoff United States
Carlos Macaya Spain
Jean‐Pierre Bassand France
Marco Roffi Switzerland
Davide Capodanno
Citations per year, relative to Davide Capodanno Davide Capodanno (= 1×) peers Marco Roffi

Countries citing papers authored by Davide Capodanno

Since Specialization
Citations

This map shows the geographic impact of Davide Capodanno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Capodanno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Capodanno more than expected).

Fields of papers citing papers by Davide Capodanno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Capodanno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Capodanno. The network helps show where Davide Capodanno may publish in the future.

Co-authorship network of co-authors of Davide Capodanno

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Capodanno. A scholar is included among the top collaborators of Davide Capodanno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Capodanno. Davide Capodanno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilson, Thomas G., Adeel Ahmed, Iqra Riaz, et al.. (2025). Precision management of coronary in-stent restenosis. Trends in Cardiovascular Medicine. 36(1). 44–55.
2.
Spagnolo, Marco, Daniele Giacoppo, Claudio Laudani, et al.. (2025). Advances in the Detection and Management of Vulnerable Coronary Plaques. Circulation Cardiovascular Interventions. 18(8). e015529–e015529. 3 indexed citations
3.
Greco, Antonio, Marco Spagnolo, Claudio Laudani, et al.. (2025). Targeting Inflammation After Acute Myocardial Infarction. Journal of the American College of Cardiology. 86(15). 1146–1169. 1 indexed citations
4.
Occhipinti, Giovanni, Claudio Laudani, Mattía Galli, et al.. (2025). Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis. European Heart Journal. 2 indexed citations
5.
Spagnolo, Marco & Davide Capodanno. (2025). Factor XI Inhibitors for Myocardial Infarction: A Safer Path to Thrombotic Protection?. Thrombosis and Haemostasis. 125(12). 1169–1172. 2 indexed citations
6.
Rosa, Giusy Rita Maria La, Juan Yu, Giulio Geraci, et al.. (2025). Vascular and Cardiovascular Outcomes of Smoking Cessation and Switching to Electronic Cigarette Use: Protocol for a Systematic Review of Prospective Studies. JMIR Research Protocols. 14. e74949–e74949.
7.
Greco, Antonio, Marco Spagnolo, Claudio Laudani, et al.. (2024). Assessment of Noninferiority Margins in Cardiovascular Medicine Trials. JACC Advances. 3(7). 101021–101021. 8 indexed citations
8.
Spagnolo, Marco, Giovanni Occhipinti, Claudio Laudani, Antonio Greco, & Davide Capodanno. (2024). Periprocedural myocardial infarction and injury. European Heart Journal Acute Cardiovascular Care. 13(5). 433–445. 9 indexed citations
9.
Gaudino, Mario, Marcus Flather, Davide Capodanno, et al.. (2024). European Association of Cardio-Thoracic Surgery (EACTS) expert consensus statement on perioperative myocardial infarction after cardiac surgery. European Journal of Cardio-Thoracic Surgery. 65(2). 4 indexed citations
10.
Spagnolo, Marco, Antonio Greco, Claudio Laudani, et al.. (2023). Asociación de las características del ensayo con la publicación simultánea y su impacto en citas y menciones: un estudio transversal. Revista Española de Cardiología. 77(4). 324–331. 1 indexed citations
11.
Greco, Antonio, Denise Cristiana Faro, Federica Agnello, et al.. (2023). Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention. The American Journal of Cardiology. 199. 7–17. 10 indexed citations
12.
Byrne, Robert A., Stephen E. Fremes, Davide Capodanno, et al.. (2023). 2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG. European Heart Journal. 44(41). 4310–4320. 25 indexed citations
13.
Galli, Mattía, Renzo Laborante, Luis Ortega‐Paz, et al.. (2023). Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis. Thrombosis and Haemostasis. 123(6). 576–584. 36 indexed citations
14.
Galli, Mattía, Davide Capodanno, Stefano Benenati, et al.. (2021). Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials. European Heart Journal - Cardiovascular Pharmacotherapy. 8(5). 519–528. 21 indexed citations
15.
Capodanno, Davide, Deepak L. Bhatt, C. Michael Gibson, et al.. (2021). Bleeding avoidance strategies in percutaneous coronary intervention. Nature Reviews Cardiology. 19(2). 117–132. 83 indexed citations
16.
Galli, Mattía, Stefano Benenati, Francesco Franchi, et al.. (2021). Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials. European Heart Journal. 43(10). 959–967. 95 indexed citations
17.
Galli, Mattía, Davide Capodanno, Felicita Andreotti, Filippo Crea, & Dominick J. Angiolillo. (2020). Safety and efficacy of P2Y12inhibitor monotherapy in patients undergoing percutaneous coronary interventions. Expert Opinion on Drug Safety. 20(1). 9–21. 21 indexed citations
18.
Tarantini, Giuseppe, Plinio Cirillo, Stefano De Servi, et al.. (2018). Scelta della duplice terapia antiaggregante nel paziente anziano con sindrome coronarica acuta: l’età fa la differenza?. Giornale italiano di cardiologia. 19(7). 420–428. 1 indexed citations
19.
Fajadet, Jean, Davide Capodanno, & Gregg W. Stone. (2018). Management of left main disease: an update. European Heart Journal. 40(18). 1454–1466. 22 indexed citations
20.
Tarantini, Giuseppe, Marco Mojoli, & Davide Capodanno. (2014). Lo studio PRAMI. Giornale italiano di cardiologia. 15(4). 199–204. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Roffi Breakdown of academic impact, for papers by Franz‐Josef Neumann Breakdown of academic impact, for papers by Pascal Vranckx Breakdown of academic impact, for papers by Howard C. Herrmann Breakdown of academic impact, for papers by Eugenia Nikolsky Breakdown of academic impact, for papers by Allan L. Klein Breakdown of academic impact, for papers by C. Michael Gibson Breakdown of academic impact, for papers by Mitchell W. Krucoff Breakdown of academic impact, for papers by Carlos Macaya Breakdown of academic impact, for papers by Jean‐Pierre Bassand
Rankless by CCL
2026